Cyclosporins

You have access
Pharmacotherapy of multiple sclerosis: current status
Richard A. Rudick, MD, Donald E. Goodkin, MD and Richard M. Ransohoff, MD

Cleveland Clinic Journal of Medicine May 1992, 59 (3) 267-277;

With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.
You have access
Experimental therapies for multiple sclerosis: current status
Donald E. Goodkin, MD, Richard M. Ransohoff, MD and Richard A. Rudick, MD

Cleveland Clinic Journal of Medicine January 1992, 59 (1) 63-74;

A critical analysis of current experimental agents and obstacles to the development of effective drug therapy.
You have access
Decreased infections in cardiac transplant recipients on cyclosporine with reduced corticosteroid use
Margaret J. Gorensek, MD, Robert W. Stewart, MD, Thomas F. Keys, MD, Martin C. McHenry, MD, David L. Longworth, MD, Susan J. Rehm, MD and Theresa Babiak, BS

Cleveland Clinic Journal of Medicine October 1989, 56 (7) 690-695;
You have access
Cyclosporine nephrotoxicity
Donald R. Steinmuller, MD

Cleveland Clinic Journal of Medicine January 1989, 56 (1) 89-95;
You have access
Cyclosporine and organ transplantation
Donald R. Steinmuller, M.D.

Cleveland Clinic Journal of Medicine June 1985, 52 (2) 263-270;

Main menu